Literature DB >> 22894664

Targeting survivin's co-conspirators: do alternative methods of trapping survivin in the nucleus have potential in triple-negative breast cancer therapy?

Michael P Holloway, Rachel A Altura.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894664     DOI: 10.2217/fon.12.77

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


× No keyword cloud information.
  2 in total

Review 1.  Association of survivin splice variants with prognosis and treatment of breast cancer.

Authors:  Anastasia Pavlidou; Christos Kroupis; Kleanthi Dimas
Journal:  World J Clin Oncol       Date:  2014-12-10

Review 2.  Targeting survivin in cancer: novel drug development approaches.

Authors:  Bernd Groner; Astrid Weiss
Journal:  BioDrugs       Date:  2014-02       Impact factor: 5.807

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.